Primary Biliary Cirrhosis and Sjögren's Syndrome: Autoimmune Epithelitis

Overview

Journal J Autoimmun

Specialty Allergy & Immunology

Date 2011 Dec 20

PMID 22178199

Citations 58

Authors

Carlo Selmi

Pier Luigi Meroni

M Eric Gershwin

Affiliations

Soon will be listed here.

Abstract

Primary biliary cirrhosis (PBC) has been often coined a model autoimmune disease based on the homogeneity amongst patients, the frequency and similarity of antimitochondrial antibodies, including the highly directed immune response to pyruvate dehydrogenase (PDC-E2). A significant number of patients with PBC suffer from sicca and amongst these, there are patients who also have classic Sjögren's syndrome. Indeed, both PBC and Sjögren's syndrome are characterized by inflammation of target epithelial elements. Both diseases can be considered on the basis of a number of other related clinical aspects, including proposed unique apoptotic features of the target tissue, the role of secretory IgA, and the frequency with which both diseases overlap with each other. Indeed, PBC may be considered a Sjögren's syndrome of the liver, whereas Sjögren's syndrome can be equally discussed as PBC of the salivary glands. Dissection of the genetic predispositions for both diseases and especially the molecular basis of effector mechanisms, will become critical elements in developing new therapies.

Citing Articles

Clinical and laboratory characteristics of Sjögren's syndrome-associated autoimmune liver disease: a real-world, 10-year retrospective study.

Liang P, Huang Y, Hu Z, Zhou L, Cai S, Zhong J Clin Rheumatol. 2025; 44(3):1225-1236.

PMID: 39826046 DOI: 10.1007/s10067-024-07273-z.

Prevalence and clinical significance of anti-SSA antibody in the Chinese health screening population.

Jia Y, Luan S, Huang S, Zhang W, Li M, Xu T Clin Exp Immunol. 2024; 218(2):169-176.

PMID: 39136066 PMC: 11482497. DOI: 10.1093/cei/uxae073.

Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease.

Juran B, McCauley B, Atkinson E, Schlicht E, Bianchi J, Vollenweider J Hepatol Commun. 2024; 8(8).

PMID: 39023332 PMC: 11262819. DOI: 10.1097/HC9.0000000000000496.

Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study.

Liu Z, Shao Y, Duan X PLoS One. 2024; 19(2):e0298225.

PMID: 38335208 PMC: 10857725. DOI: 10.1371/journal.pone.0298225.

Rare renal proximal tubular dysfunctions in primary biliary cholangitis.

Shi X, Guo T, Wen Y, Ye W, Ye W, Zheng K Ren Fail. 2024; 46(1):2302409.

PMID: 38275162 PMC: 10823888. DOI: 10.1080/0886022X.2024.2302409.

References

Padgett K, Lan R, Leung P, Lleo A, Dawson K, Pfeiff J . Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun. 2009; 32(3-4):246-53. PMC: 2698796. DOI: 10.1016/j.jaut.2009.02.022. View

Oertelt S, Ridgway W, Ansari A, Coppel R, Gershwin M . Murine models of primary biliary cirrhosis: Comparisons and contrasts. Hepatol Res. 2007; 37 Suppl 3:S365-9. DOI: 10.1111/j.1872-034X.2007.00226.x. View

Stojakovic T, Putz-Bankuti C, Fauler G, Scharnagl H, Wagner M, Stadlbauer V . Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology. 2007; 46(3):776-84. DOI: 10.1002/hep.21741. View

Leslie W, Bernstein C, LeBoff M . AGA technical review on osteoporosis in hepatic disorders. Gastroenterology. 2003; 125(3):941-66. DOI: 10.1016/s0016-5085(03)01062-x. View

Janka C, Selmi C, Gershwin M, Will H, Sternsdorf T . Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis. Hepatology. 2005; 41(3):609-16. DOI: 10.1002/hep.20619. View

Coppel R, Mackay I, Bass N, Ansari A, Gershwin M . The immunobiology of bile and biliary epithelium. Hepatology. 1999; 30(2):351-7. DOI: 10.1002/hep.510300218. View

Allocca M, Crosignani A, Gritti A, Ghilardi G, Gobatti D, Caruso D . Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut. 2006; 55(12):1795-800. PMC: 1856484. DOI: 10.1136/gut.2005.079814. View

Triger D, Berg P, Rodes J . Epidemiology of primary biliary cirrhosis. Liver. 1984; 4(3):195-200. DOI: 10.1111/j.1600-0676.1984.tb00927.x. View

Lindor K, Gershwin M, Poupon R, Kaplan M, Bergasa N, Heathcote E . Primary biliary cirrhosis. Hepatology. 2009; 50(1):291-308. DOI: 10.1002/hep.22906. View

10.

Skopouli F, Barbatis C, Moutsopoulos H . Liver involvement in primary Sjögren's syndrome. Br J Rheumatol. 1994; 33(8):745-8. DOI: 10.1093/rheumatology/33.8.745. View

11.

Lu Q, Renaudineau Y, Cha S, Ilei G, Brooks W, Selmi C . Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium. Autoimmun Rev. 2010; 9(9):627-30. DOI: 10.1016/j.autrev.2010.05.011. View

12.

Rigamonti C, Shand L, Feudjo M, Bunn C, Black C, Denton C . Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut. 2005; 55(3):388-94. PMC: 1856066. DOI: 10.1136/gut.2005.075002. View

13.

Shoenfeld Y, Selmi C, Zimlichman E, Gershwin M . The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun. 2008; 31(4):325-30. DOI: 10.1016/j.jaut.2008.08.004. View

14.

Chiorini J, cihakova D, Ouellette C, Caturegli P . Sjögren syndrome: advances in the pathogenesis from animal models. J Autoimmun. 2009; 33(3-4):190-6. PMC: 3439154. DOI: 10.1016/j.jaut.2009.09.009. View

15.

Agmon-Levin N, Shapira Y, Selmi C, Barzilai O, Ram M, Szyper-Kravitz M . A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun. 2009; 34(1):55-8. DOI: 10.1016/j.jaut.2009.08.009. View

16.

Invernizzi P . Geoepidemiology of autoimmune liver diseases. J Autoimmun. 2009; 34(3):J300-6. DOI: 10.1016/j.jaut.2009.12.002. View

17.

Yoshida K, Yang G, Zhang W, Tsuda M, Tsuneyama K, Moritoki Y . Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology. 2009; 50(5):1494-500. PMC: 2783300. DOI: 10.1002/hep.23132. View

18.

Benetti A, Crosignani A, Varenna M, Giussani C, Allocca M, Zuin M . Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study. J Clin Gastroenterol. 2008; 42(3):306-11. DOI: 10.1097/01.mcg.0000248017.31386.39. View

19.

Tsianos E, Hoofnagle J, Fox P, Alspaugh M, Jones E, Schafer D . Sjögren's syndrome in patients with primary biliary cirrhosis. Hepatology. 1990; 11(5):730-4. DOI: 10.1002/hep.1840110504. View

20.

Lleo A, Selmi C, Invernizzi P, Podda M, Coppel R, Mackay I . Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology. 2009; 49(3):871-9. PMC: 2665925. DOI: 10.1002/hep.22736. View